These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 15803142)

  • 21. Epstein-Barr virus latent membrane protein 1 induces micronucleus formation, represses DNA repair and enhances sensitivity to DNA-damaging agents in human epithelial cells.
    Liu MT; Chen YR; Chen SC; Hu CY; Lin CS; Chang YT; Wang WB; Chen JY
    Oncogene; 2004 Apr; 23(14):2531-9. PubMed ID: 14716302
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Resistance to fludarabine-induced apoptosis in Epstein-Barr virus infected B cells.
    Fagard R; Mouas H; Dusanter-Fourt I; Devillers C; Bissières P; Martin A; Lenoir G; VanTan H; Feuillard J; Raphaël M
    Oncogene; 2002 Jul; 21(29):4473-80. PubMed ID: 12085225
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Expression of the Epstein Barr virus transforming protein LMP1 causes a rapid and transient stimulation of the Bcl-2 homologue Mcl-1 levels in B-cell lines.
    Wang S; Rowe M; Lundgren E
    Cancer Res; 1996 Oct; 56(20):4610-3. PubMed ID: 8840972
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Latent membrane protein 1 of Epstein-Barr virus coordinately regulates proliferation with control of apoptosis.
    Dirmeier U; Hoffmann R; Kilger E; Schultheiss U; Briseño C; Gires O; Kieser A; Eick D; Sugden B; Hammerschmidt W
    Oncogene; 2005 Mar; 24(10):1711-7. PubMed ID: 15674340
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Exosomes released by EBV-infected nasopharyngeal carcinoma cells convey the viral latent membrane protein 1 and the immunomodulatory protein galectin 9.
    Keryer-Bibens C; Pioche-Durieu C; Villemant C; Souquère S; Nishi N; Hirashima M; Middeldorp J; Busson P
    BMC Cancer; 2006 Dec; 6():283. PubMed ID: 17156439
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Epstein-Barr virus (EBV) latent membrane protein-1-specific cytotoxic T lymphocytes targeting EBV-carrying natural killer cell malignancies.
    Demachi-Okamura A; Ito Y; Akatsuka Y; Tsujimura K; Morishima Y; Takahashi T; Kuzushima K
    Eur J Immunol; 2006 Mar; 36(3):593-602. PubMed ID: 16479544
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Decoy receptor 3, upregulated by Epstein-Barr virus latent membrane protein 1, enhances nasopharyngeal carcinoma cell migration and invasion.
    Ho CH; Chen CL; Li WY; Chen CJ
    Carcinogenesis; 2009 Aug; 30(8):1443-51. PubMed ID: 19483191
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The latent membrane protein 1 oncogene modifies B-cell physiology by regulating autophagy.
    Lee DY; Sugden B
    Oncogene; 2008 May; 27(20):2833-42. PubMed ID: 18037963
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Triptolide inhibits proliferation of Epstein-Barr virus-positive B lymphocytes by down-regulating expression of a viral protein LMP1.
    Zhou H; Guo W; Long C; Wang H; Wang J; Sun X
    Biochem Biophys Res Commun; 2015 Jan; 456(3):815-20. PubMed ID: 25511707
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Clonability and tumorigenicity of human epithelial cells expressing the EBV encoded membrane protein LMP1.
    Hu LF; Chen F; Zheng X; Ernberg I; Cao SL; Christensson B; Klein G; Winberg G
    Oncogene; 1993 Jun; 8(6):1575-83. PubMed ID: 8389032
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Role of Epstein-Barr virus encoded latent membrane protein 1 in the carcinogenesis of nasopharyngeal carcinoma.
    Zheng H; Li LL; Hu DS; Deng XY; Cao Y
    Cell Mol Immunol; 2007 Jun; 4(3):185-96. PubMed ID: 17601372
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Nuclear accumulation of epidermal growth factor receptor and acceleration of G1/S stage by Epstein-Barr-encoded oncoprotein latent membrane protein 1.
    Tao Y; Song X; Deng X; Xie D; Lee LM; Liu Y; Li W; Li L; Deng L; Wu Q; Gong J; Cao Y
    Exp Cell Res; 2005 Feb; 303(2):240-51. PubMed ID: 15652339
    [TBL] [Abstract][Full Text] [Related]  

  • 33. EBV-LMP1-targeted DNAzyme restrains nasopharyngeal carcinoma growth in a mouse C666-1 xenograft model.
    Ke X; Yang YC; Hong SL
    Med Oncol; 2011 Dec; 28 Suppl 1():S326-32. PubMed ID: 20862567
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Epstein-Barr virus LMP1 initiates cell proliferation and apoptosis inhibition via regulating expression of Survivin in nasopharyngeal carcinoma.
    Faqing T; Zhi H; Liqun Y; Min T; Huanhua G; Xiyun D; Ya C
    Exp Oncol; 2005 Jun; 27(2):96-101. PubMed ID: 15995625
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Analysis of LMP1 variants of EBV in Southern Thailand: evidence for strain-associated T-cell tropism and pathogenicity.
    Saechan V; Mori A; Mitarnun W; Settheetham-Ishida W; Ishida T
    J Clin Virol; 2006 Jun; 36(2):119-25. PubMed ID: 16616610
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Inhibition of hepatitis B virus X gene expression by 10-23 DNAzymes.
    Hou W; Ni Q; Wo J; Li M; Liu K; Chen L; Hu Z; Liu R; Hu M
    Antiviral Res; 2006 Dec; 72(3):190-6. PubMed ID: 16930733
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The relationships between Epstein-Barr virus latent membrane protein 1 and regulatory T cells in Hodgkin's lymphoma.
    Marshall NA; Culligan DJ; Tighe J; Johnston PW; Barker RN; Vickers MA
    Exp Hematol; 2007 Apr; 35(4):596-604. PubMed ID: 17379070
    [TBL] [Abstract][Full Text] [Related]  

  • 38. DNAzyme-mediated cleavage of survivin mRNA and inhibition of the growth of PANC-1 cells.
    Liang Z; Wei S; Guan J; Luo Y; Gao J; Zhu H; Wu S; Liu T
    J Gastroenterol Hepatol; 2005 Oct; 20(10):1595-602. PubMed ID: 16174080
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Epstein-Barr virus transforming protein LMP1 plays a critical role in virus production.
    Ahsan N; Kanda T; Nagashima K; Takada K
    J Virol; 2005 Apr; 79(7):4415-24. PubMed ID: 15767441
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Relationship between EBV infection and expression of cellular proteins c-Myc, Bcl-2, and Bax in gastric carcinomas.
    Lima MA; Ferreira MV; Barros MA; Pardini MI; Ferrasi AC; Mota RM; Rabenhorst SH
    Diagn Mol Pathol; 2008 Jun; 17(2):82-9. PubMed ID: 18382371
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.